INTRODUCTION {#sec0005}
============

Psychosis is one of the common and disruptive conditions that occurs with Alzheimer's disease (AD). It is estimated that approximately 40% of patients with AD experience psychotic symptoms during the course of their illness \[[@ref001]\]. Psychosis refers to a range of symptoms, generally categorized into delusions and hallucinations. Common delusional symptoms in AD include delusions of persecution, abandonment, infidelity, and misidentification. Hallucination symptoms are typically visual and auditory, but visual hallucinations are more common in AD \[[@ref002]\]. Psychosis is often accompanied by behavioral disturbances \[[@ref003]\] and a greater rate of cognitive decline \[[@ref007]\], causing significant distress to both the patients and their caregivers \[[@ref010]\]. However, the pathophysiology behind psychosis in AD remains largely unknown, limiting the ability to properly manage and treat patients.

Increasingly, cerebrovascular disease has been recognized as an important risk factor for the clinical manifestations of AD \[[@ref012]\]. Several studies have shown that vascular factors significantly increase the likelihood of dementia \[[@ref017]\]. Only recently, the role of cerebrovascular disease on psychosis in AD has been investigated. A study by Fischer and colleagues showed that vascular risk factors, but not plaque or tangle burden, are associated with psychosis in AD \[[@ref018]\]. Other studies suggest that the presence of vascular pathology in certain regions of the brain, such as lacunar infarcts in the basal ganglia, impose a higher risk of developing delusional symptoms \[[@ref019]\]. In the present study, we investigate the association between vascular risk factors and vascular pathology on cognitive and functional status and psychosis in patients with high probability of AD, corresponding to severe pathology. Furthermore, we examine whether or not vascular pathology is the mechanism through which vascular risk factors mediate the development ofpsychosis.

MATERIALS AND METHODS {#sec0010}
=====================

Data source and subject criteria {#sec0015}
--------------------------------

Data was obtained from the National Alzheimer's Coordinating Centre (NACC) encompassing records from approximately 30 Alzheimer's Disease Centers across the United States. The Uniform Data Set (UDS) and Neuropathology Data Set (NP) collected between September 2005 and December 2015 were analyzed.

The UDS was used to obtain demographical and clinical data. The demographic variables include age, sex, and education. The clinical variables comprise of informant-reported history of vascular risk factors, including hypertension, hypercholesterolemia, diabetes, and smoking (smoked more than 100 cigarettes in lifetime, total years smoked, and average number of packs per day). Clinician-reports for vascular risk factors were collected recently, and thus do not have corresponding neuropathology data. The duration of illness was calculated based on clinician's assessment on age at cognitive decline and age of death. The UDS was also used to collect clinician-reported scores on Mini-Mental State Examination (MMSE), Functional Activity Questionnaire (FAQ), and Global Clinical Dementia Rating (CDR). The presence and severity of psychotic symptoms (mild, moderate, severe), i.e., delusions or hallucinations in the month prior to the interview based on Neuropsychiatric Inventory Questionnaire, Quick version (NPI-Q) were also collected. The criteria for delusions on the NPI-Q are mainly persecutory delusions. The hallucinations symptoms include both visual and auditory hallucinations.

The NP was used to evaluate the severity of AD pathology, based on the density of neocortical neuritic plaque (CERAD score) and the Braak Stage for neurofibrillary degeneration. The NP was also used to collect data on the presence of vascular pathology, including microinfarcts (old microinfarcts not observed grossly), lacunae (small artery infarcts and/or hemorrhages less than 1 cm), cerebral amyloid angiopathy (CAA), arteriosclerosis, and white matter rarefaction (subcortical arteriosclerotic leukoencephalopathy). The severity of white matter rarefaction (none, mild, moderate, or severe), which was recorded beginning in January 2014, was further categorized into minor (if none or mild) or major (if moderate or severe) severity of white matter rarefaction. Lewy body pathology was categorized as absent (if no Lewy bodies were found) or present (if Lewy bodies were observed in the brainstem, limbic region or amygdala, neocortical, olfactory bulb, or regions unspecified) as determined by alpha-synuclein immunohistochemistry.

Patients with other primary etiological diagnosis, including brain injury, CNS neoplasm, Down's syndrome, and Huntington's disease on the UDS were excluded from the analysis. Subjects with high probability of AD based on the NIA/AA Reagan criteria, with CERAD score of 'frequent neuritic plaque' and Braak stage of V or VI were included (thus corresponding to severe AD pathology) \[[@ref020]\].

Any positive score for delusions or hallucinations at any visit during the course of a patient's illness was considered positive for psychosis. Patients were categorized into never psychotic (AD-P), psychotic (AD+P), delusions only (AD+D), hallucinations only (AD+H), or co-occurrence of delusions and hallucinations (AD+DH).

Statistical analysis {#sec0020}
--------------------

All the statistical analyses were done using the statistical software SPSS Statistics 23.0. Each of the categories of psychosis, AD+P, AD+D, AD+H, and AD+DH were independently analyzed against the AD-P group. The *χ*^2^ test was used to analyze categorical data. The independent samples *t*-test was used for continuous data with normal distribution. The Mann-Whitney test was used for continuous data if Kolmogorov-Smirnov test of normality was statistically significant. The ordinal regression analysis was used for ordinal data. ANCOVA was used when accounting for variance in the demographic or clinical characteristics between the diagnostic groups. No correction was applied for multiple testing. Statistical significance was assessed using α= 0.05.

RESULTS {#sec0025}
=======

The previous study by Fischer and colleagues using the NACC database collected between September 2005 and May 2012 identified 664 patients with high probability of AD using the NIA/AA Reagan criteria \[[@ref018]\]. In our study, we identified 1459 patients with high probability of AD, which includes overlapping patients from the previous study. Within this group, we identified 734 AD-P, 326 AD+D, 170 AD+H, and 229 AD+DH.

Demographic and clinical characteristics {#sec0030}
----------------------------------------

Subjects in the AD+P and AD+H were significantly younger at age of clinical visit compared to the AD-P counterparts. Subjects in the AD+H group were also younger at age at death. The age of onset of cognitive decline based on clinician's assessment was not statistically different between the diagnostic groups. The duration of illness was shorter in the AD+H group compared to the AD-P group. The interval between last clinical visit and death was significantly shorter in all categories of psychosis compared to the AD-P counterparts. The average interval between last clinical visit and death were under two years in all of the diagnostic categories. There were no statistical differences between psychotic status and sex ([Table 1](#jad-55-jad160506-t001){ref-type="table"}).

Vascular pathologies, Lewy bodies, and cognitive and functional status {#sec0035}
----------------------------------------------------------------------

Within our criteria of high probability of AD, there were no significant associations between vascular pathologies and cognitive or functional status, based on the MMSE, FAQ, and global CDR scores. The presence of Lewy body pathology was associated with lower MMSE scores, and higher FAQ scores, corresponding to greater cognitive and functional impairments ([Table 2](#jad-55-jad160506-t002){ref-type="table"}).

Vascular risk factors and vascular pathology {#sec0040}
--------------------------------------------

A history of vascular risk factors was positively associated with certain vascular pathologies. Patients with a history of hypertension were significantly more likely to have microinfarcts, lacunae, and white matter rarefaction on pathological examination. Patients with a history of hypercholesterolemia or diabetes were more likely to have lacunae. A history of smoking was significantly associated with presence of white matter rarefaction. Lewy body pathology was negatively associated with hypertension, and was not associated with other vascular risk factors analyzed in this study ([Table 3](#jad-55-jad160506-t003){ref-type="table"}).

Association of vascular risk factors, vascular pathologies, and Lewy bodies with psychosis {#sec0045}
------------------------------------------------------------------------------------------

In accordance with the previous study by Fischer and colleagues, we found a significant association between presence of psychosis and hypertension or diabetes \[[@ref018]\]. This association was specific to patients with delusions and co-occurrence of delusions and hallucinations ([Table 4](#jad-55-jad160506-t004){ref-type="table"}). We did not find any associations between the presence of microinfarcts, lacunae, CAA, and arteriosclerosis and psychosis. However, a significant association was found between white matter rarefaction and psychosis, specifically AD+H. The presence of Lewy body pathology was positively associated with the AD+P, AD+H, and AD+DH group compared to AD-P ([Table 4](#jad-55-jad160506-t004){ref-type="table"}).

Vascular pathology as mediator {#sec0050}
------------------------------

Given that vascular risk factors and vascular pathologies are linked, and independently associated with psychosis, we then investigated whether vascular pathologies are the mediators through which vascular risk factors affect psychosis. However, in patients with a history of vascular risk factors,vascular pathologies, including white matter rarefaction, were not more common in any of the subgroups of psychosis compared to the AD-P group ([Table 5](#jad-55-jad160506-t005){ref-type="table"}). Lewy body pathology was not analyzed as a mediator because their only association with a vascular risk factor (hypertension) is negative. However, since Lewy bodies are positively associated with psychosis, their presence was used as a covariate in the analysis.

DISCUSSION {#sec0055}
==========

Several longitudinal studies in the elderly population have suggested that cerebrovascular disease is associated with increased likelihood of dementia \[[@ref021]\]. However, an evidence-based review by Chui and colleagues show that there are no associations between vascular risk factors and AD pathology \[[@ref028]\]. Studies with neuropathological confirmation have reported that the association between vascular pathology and dementia was observed only in patients with low to moderate, but not severe AD pathology \[[@ref029]\]. Consistent with these findings, the present study shows that vascular pathologies do not affect cognitive or functional performance in subjects with high severity of AD pathology.

Importantly, our study confirms the finding that vascular risk factors are associated with increased risk of psychosis, specifically delusions \[[@ref018]\]. However, the mechanism through which vascular risk factors affect the onset of psychosis remains unknown. In our study, we examined the role of vascular pathology as an intermediate mechanism through which vascular risk factors affect the onset of psychosis. We confirmed that risk factors are positively associated with vascular pathology, including microinfarcts, lacunae, and white matter rarefaction. Only one type ofvascular pathology, specifically presence of white matter rarefaction, was related to a form of psychosis, hallucinations. Furthermore, vascular pathology in the presence of vascular risk factors did not increase the likelihood of psychosis, indicating that the contributions of hypertension or diabetes to the development of psychosis are mediated by mechanisms other than vascular lesions. Alternatively, the location,rather than the presence of vascular lesions, would be the critical factor, but this is not the case when the effects of vascular lesions on cognitive performance in subjects with moderate AD load are considered \[[@ref029]\]. Previous studies on white matter hyperintensities on psychosis have produced mixed results. Many studies show no correlation between periventricular and white matter hyperintensities and psychosis \[[@ref031]\]. Other studies indicate that regional white matter hyperintensities affect development of delusional symptoms \[[@ref034]\]. However, these findings on white matter hyperintensities are derived from imaging studies. The results from our study based on neuropathological data suggest that white matter rarefaction increases the likelihood of psychosis, specifically hallucinations.

There are some limitations to the present study. One of the limitations of the study is that multiple univariate tests were employed in the statistical analysis, which may inflate the rate of type I error. We, as others before us, have not corrected for multiple testing in this exploratory stage \[[@ref036]\]. Another limitation is the time gap between last clinical visit and the time of death. The average time interval between last clinical visit and death in years was within two years, but the progression of the illness possibly varied among the subject population.

Furthermore, vascular risk factors analyzed in this study are subject or caregiver reported historical data, and whether the condition is still active or has been treated is not available. The NACC database started to implement clinician-reported measures since 2015, which would provide a numerical evaluation for accessing vascular risk factors at time of the visit. With respect to our analysis on cognitive performance, the results may be reflective of a floor effect given that patients with severe AD have limited functional and cognitive capacity. The choice of high AD pathology load is inseparable from high probability that the dementia is due to AD, the rationale for our choice of inclusion criterion. The presentation of psychosis collected on the NPI-Q also introduces some limitations. First of all, NPI-Q records presentation of psychosis during the last month prior to clinical visit, and does not take into account the trajectory of psychotic symptoms over time. Secondly, the criteriafor delusions on NPI-Q are persecutory delusions. Therefore, the association between vascular risk factors and other types of delusions in AD remains to be further investigated.

In summary, we demonstrate the importance of cerebrovascular disease in the clinical manifestation of psychosis, but not in cognitive performance in subjects with severe AD pathology. However, the mechanism through which vascular risk factors affects psychosis is not mediated through just the presence of vascular pathology. It is possible that vascular risk factors and vascular lesions trigger widespread alterations in the brain, which in the presence of moderate AD load results in cognitive impairment, but in the presence of severe AD results in psychosis. Prospective studies investigating the trajectories of vascular pathology and clinical manifestation AD will help to better understand the pathophysiology of AD.
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###### 

The demographic and clinical distribution of subjects within each diagnostic categories (AD-P Never psychotic; AD+P Psychotic; AD+D Delusions only; AD+H Hallucinations only; AD+DH Co-occurrence of delusions and hallucinations). Each of the psychotic categories were independently analyzed against the non-psychotic group (AD-P)

                                      AD-P      AD+P         AD+D        AD+H        AD+DH                                                          
  -------------------------------- ----------- ------- ---------------- ------- ---------------- ------- ----------------- ------- ---------------- -------
  Age at clinical visit             734/77.09   10.58   725/76.02^\*^    10.78     326/77.08      10.24   170/74.43^\*\*^   10.84     229/75.68      11.35
  Age at death                      734/78.91   10.4      725/78.11      10.82     326/79.34      10.22   170/76.35^\*\*^   10.99     229/77.66      11.35
  Interval between last clinical    734/1.80    1.77    725/1.31^\*\*^   1.35    326/1.45^\*\*^   1.49    170/1.28^\*\*^    1.32    229/1.14^\*\*^   1.14
    visit and death in years                                                                                                                        
  Age onset                         714/69.13   10.59     720/68.20      10.75     324/69.43      10.33      168/66.52      10.52     228/67.68      11.34
  Duration of Illness               714/9.56    3.93       720/9.95      3.97       324/9.90      3.84    168/9.93^\*\*^    4.23      228/10.03      3.95
  Sex                                                                                                                                               
    Males                              411       56%         383          53%         176          54%          92           54%         115          50%
    Females                            323       44%         342          47%         150          46%          78           46%         114          50%

^\*^*p* = 0.010 to 0.050; ^\*\*^*p* ≤ 0.010.

###### 

The distribution of vascular lesions, Lewy bodies, and cognitive and functional impairments

                                  MMSE       FAQ     Global CDR                     
  ---------------------------- ----------- -------- ------------ ------ ----------- ------
  *Microinfarcts*                                                                   
  Absent                        888/12.73    8.47    1236/25.25   7.15   1253/2.15   0.88
  Present                       180/12.97    8.20    256/25.51    6.47   260/2.15    0.87
  *Lacunae*                                                                         
  Absent                        728/12.40    8.45    999/25.57    6.87   1017/2.17   0.87
  Present                       128/12.40    9.07    181/25.49    7.22   183/2.22    0.88
  *White matter rarefaction*                                                        
  Absent                        837/12.61    8.46    1247/25.27   7.08   1164/2.15   0.88
  Present                       193/12.74    8.28    301/26.04    6.30   305/2.24    0.84
  *Lewy bodies*                  ^\*\*^     ^\*\*^                                  
  Absent                        622/13.45    8.50    900/24.98    7.44   915/2.13    0.90
  Present                       442/11.82    8.24    587/25.75    6.36   592/2.16    0.85

^\*^*p* = 0.010 to 0.050; ^\*\*^*p*≤0.010.

###### 

The distribution of vascular risk factors, vascular pathologies, and Lewy bodies in subjects with severe Alzheimer's disease pathology

                                               Microinfarcts   Lacunae   White matter rarefaction   Lewy bodies                                                                                                                   
  ------------------------------------------- --------------- --------- -------------------------- ------------- ----------- ------- ----------- ------- ----------- ------- ----------- ------- ------------ ------- ----------- -------
  *Hypertension*                                  ^\*\*^       ^\*\*^              ^\*^                ^\*^                                                                                                                       
    Absent                                          624          55%                99                  40%          518       55%       62        38%       488       54%       87        45%       419        50%       301       55%
    Present                                         516          45%               147                  60%          420       45%       103       62%       413       46%       108       55%       418        50%       243       45%
  *Hypercholesterolemia*                           ^\*^                                                                                                                                                                           
    Absent                                          593          53%               115                  50%          511       56%       75        46%       486       55%       98        52%       439        54%       264       50%
    Present                                         526          47%               117                  50%          408       44%       87        54%       398       45%       92        48%       376        50%       266       50%
  *Diabetes*                                      ^\*\*^                                                                                                                                                                          
    Absent                                         1127          91%               228                  88%          927       92%       150       84%       885       91%       187       93%       815        90%       535       91%
    Present                                         109          9%                 31                  12%          77        8%        29        16%       89        9%        15        7%         87        10%       52        9%
  *Smoked more than 100 cigarettes in life*        ^\*^                                                                                                                                                                           
    No                                              666          54%               127                  50%          520       52%       98        55%       522       54%       92        45%       504        56%       285       50%
    Yes                                             560          46%               125                  50%          472       48%       79        45%       436       46%       112       55%       393        44%       290       50%
  *Total years smoked cigarettes*               1175/11.26      16.58           236/11.50              17.38      842/11.71   16.93   168/12.09   17.97   919/11.40   16.97   184/13.47   17.57   862 /10.77   16.64   544/12.10   16.66
  *Average number of packs smoked per day*         ^\*^                                                                                                                                                                           
    No Reported Cigarette                           655          56%               126                  54%          511       55%       96        56%       512       56%       91        49%       497        58%       280       52%
    1 cigarette to less than 1/2 pack               152          13%                29                  12%          117       13%       18        11%       113       12%       22        12%       102        12%       78        14%
    1/2 pack to less than 1 pack                    179          15%                36                  15%          148       16%       27        16%       140       15%       35        19%       122        14%       92        17%
    1 pack to 11/2 packs                            105          9%                 18                  8%           91        10%       14        8%        84        9%        18        10%        74        9%        49        9%
    11/2 packs to 2 packs                           44           4%                 9                   4%           34        4%         8        5%        32        4%        10        5%         31        4%        22        4%
    More than 2 Packs                               33           3%                 15                  6%           34        4%         7        4%        32        4%         9        5%         31        4%        17        3%

^\*^*p* = 0.010 to 0.050; ^\*\*^*p*≤0.010.

###### 

The distribution of vascular risk factors, vascular pathologies, and degenerative pathology in each of the diagnostic categories of psychosis (AD-P Never psychotic; AD+P Psychotic; AD+D Delusions only AD+H Hallucinations only; AD+DH Co-occurrence of delusions and hallucinations). Each of the psychotic categories were independently analyzed against the non-psychotic group (AD-P)

                                                 AD-P      AD+P      AD+D      AD+H      AD+DH                                           
  ------------------------------------------- ----------- ------- ----------- ------- ----------- ------- ---------- ------- ----------- -------
  **Vascular Risk Factors**                                                                                                              
  *Hypertension*                                                    ^\*\*^              ^\*\*^                                  ^\*^     
    Absent                                        369       56%       327       49%       145       47%       82       55%       100       47%
    Present                                       292       44%       347       51%       165       53%       67       45%       115       53%
  *Hypercholesterolemia*                                                                                                                 
    Absent                                        346       53%       328       50%       143       49%       83       56%       102       49%
    Present                                       306       47%       322       50%       151       51%       66       44%       105       51%
  *Diabetes*                                                                             ^\*^                                   ^\*^     
    Absent                                        672       92%       639       89%       288       89%      155       95%       196       87%
    Present                                       57        8%        75        11%       36        11%       9        5%        30        13%
  *Smoked more than 100 cigarettes in life*                                                                                              
    No                                            371       51%       392       55%       371       51%       92       55%       126       56%
    Yes                                           351       49%       319       45%       351       49%       75       45%       100       44%
  *Total years smoked cigarettes*              692/11.78   16.93   675/11.00   16.62   303/11.22   16.63   158/9.49   14.66   214/11.79   17.91
  *Average number of packs smoked per day*                                                                                               
    No Reported Cigarette                         362       49%       389       54%       172       53%       91       54%       126       55%
    1 cigarette to less than 1/2 pack             93        13%       86        11%       35        11%       22       13%       29        13%
    1/2 pack to less than 1 pack                  119       16%       90        12%       42        13%       1        11%       29        13%
    1 pack to 11/2 packs                          62        8%        55        8%        22        7%        12       7%        21        9%
    1 1/2 packs to 2 packs                        25        3%        28        4%        15        5%        4        2%         9        4%
    More than 2 Packs                             25        3%        23        3%        11        3%        9        5%         3        1%
  **Vascular Pathology**                                                                                                                 
  *Microinfarcts*                                                                                                                        
    Absent                                        599       82%       608       84%       267       82%      149       88%       192       84%
    Present                                       134       18%       117       16%       59        18%       21       12%       37        16%
  *Lacunae*                                                                                                                              
    Absent                                        483       86%       487       85%       210       84%      131       91%       146       81%
    Present                                       80        14%       87        15%       40        16%       13       9%        34        19%
  *Cerebral Amyloid Angiopathy (CAA)*                                                                                                    
    None                                          141       19%       128       18%       55        17%       31       18%       42        18%
    Mild                                          252       34%       242       33%       104       32%       55       32%       83        36%
    Moderate                                      199       27%       197       27%       94        29%       48      28.%       55        24%
    Severe                                        129       18%       136       19%       69        21%       28       16%       39        17%
  *White matter rarefaction*                                                                                 ^\*^                        
    Absent                                        481       84%       454       80%       204       82%      111       78%       139       78%
    Present                                       89        16%       116       20%       44        18%       32       22%       40        22%
  *Arteriolosclerosis*                                                                                                                   
    None                                          134       18%       123       17%       54        17%       28       17%       41        18%
    Mild                                          213       29%       219       30%       99        30%       48       28%       72        31%
    Moderate                                      190       26%       187       26%       89        27%       47       28%       51        22%
    Severe                                        90        12%       102       14%       45        14%       20       12%       37        16%
  **Degenerative Pathology**                                                                                                             
  *Lewy bodies*                                                     ^\*\*^                                  ^\*\*^             ^\*\*^    
    Absent                                        467       64%       402       56%       196       60%       87       51%       119       52%
    Present                                       262       36%       322       44%       130       40%       83       49%       109       48%

^\*^*p* = 0.010 to 0.050; ^\*\*^*p*≤0.010.

###### 

The distribution of vascular lesions and psychosis each diagnostic categories of psychosis in presence of vascular risk factors in subjects with high probability of AD. (AD-P Never psychotic; AD+P Psychotic; AD+D Delusions only; AD+H Hallucinations only; AD+DH Co-occurrence of delusions and hallucinations). Each of the psychotic categories were independently analyzed against the non-psychotic group (AD-P)

                                           AD-P   AD+P   AD+D   AD+H   AD+DH                         
  --------------------------------------- ------ ------ ------ ------ ------- ----- ---- ----- ----- -----
  **History of Hypertension +**                                                                      
  *Microinfarcts*                                                                                    
    Absent                                 223    77%    274    79%     127    77%   58   87%   89    77%
    Present                                 68    23%     73    21%     38     23%   9    13%   26    23%
  *Lacunae*                                                                                          
    Absent                                 183    81%    217    79%     97     78%   52   90%   68    75%
    Present                                 43    19%     56    21%     27     22%   6    10%   23    25%
  *White matter rarefaction*                                                                         
    Absent                                 216    77%    258    76%     129    80%   49   74%   80    71%
    Present                                 65    23%     82    24%     32     20%   17   26%   33    29%
  **History of Hypercholesterolemia +**                                                              
  *Microinfarcts*                                                                                    
    Absent                                 244    80%    270    84%     127    84%   58   88%   85    81%
    Present                                 62    20%     52    16%     24     16%   8    12%   20    19%
  *Lacunae*                                                                                          
    Absent                                 194    84%    203    82%     87     78%   53   91%   63    79%
    Present                                 37    16%     46    18%     24     22%   5    9%    17    21%
  *White matter rarefaction*                                                                         
    Absent                                 231    80%    246    78%     117    79%   53   82%   76    75%
    Present                                 58    20%     68    22%     31     21%   12   18%   25    25%
  **History of Smoking +**                                                                           
  *Microinfarcts*                                                                                    
    Absent                                 282    80%    266    85%     117    81%   65   87%   84    88%
    Present                                 69    20%     48    15%     27     19%   10   13%   11    12%
  *Lacunae*                                                                                          
    Absent                                 241    85%    218    86%     99     86%   59   94%   60    79%
    Present                                 41    15%     36    14%     16     14%   4    6%    16    21%
  *White matter rarefaction*                                                                         
    Absent                                 282    79%    302    79%     128    77%   73   80%   101   82%
    Present                                 74    21%     79    21%     39     23%   18   20%   22    18%

^\*^*p* = 0.010 to 0.050; ^\*\*^*p* ≤ 0.010.
